Peer-reviewedCC BYAmerican journal of physiology. Heart and circulatory physiology
Unraveling the NO–sGC–cGMP Pathway in BPD-Associated Pulmonary Hypertension
- 1Division of Respiratory, Critical Care, and Occupational Pulmonary Medicine, University of Utah, Department of Internal Medicine, Salt Lake City, UT
Related
- β‐sitosterol Alleviates Pulmonary Arterial Hypertension in Rats With Involvement of the VEGF/PI3K/AKT Signaling Pathway
- Mechanisms and Advances in the Treatment of Arrhythmias Associated With Pulmonary Hypertension
- Prevalence and factors associated with pulmonary hypertension in patients undergoing maintenance hemodialysis: a systematic review and meta-analysis
- Natriuretic Peptide Receptor-C (NPR3) in Pulmonary Hypertension Associated with Chronic Lung Disease: A PRISMA-ScR Scoping Review of Diagnostic, Prognostic, Mechanistic, and Therapeutic Evidence
- Sotatercept-related peripheral microvascular alterations in systemic sclerosis–associated pulmonary arterial hypertension: insights from nailfold capillaroscopy
BibTeX
@article{james2026unraveling,
title = {{Unraveling the NO–sGC–cGMP Pathway in BPD-Associated Pulmonary Hypertension}},
author = {Kimra S. James and My N. Helms},
journal = {American journal of physiology. Heart and circulatory physiology},
year = {2026},
month = sep,
doi = {10.1152/ajpheart.90017.2026},
url = {https://doi.org/10.1152/ajpheart.90017.2026},
note = {CC BY},
}
RIS
TY - JOUR
TI - Unraveling the NO–sGC–cGMP Pathway in BPD-Associated Pulmonary Hypertension
AU - Kimra S. James
AU - My N. Helms
PY - 2026
DA - 2026/09/08
JO - American journal of physiology. Heart and circulatory physiology
DO - 10.1152/ajpheart.90017.2026
UR - https://doi.org/10.1152/ajpheart.90017.2026
SN - 0363-6135
SN - 1522-1539
ER -